Nepsezai

Kantipur Pharmaceuticals Lab Limited (KPLL) IPO

The general public issue of 17,00,000 units at Rs 100 ran from — to —. SEBON has approved an issue of 17,00,000 units (Rs 17,00,00,000) for the general public; no opening date has been announced yet. Issue manager: Muktinath Capital Limited.

Applications have closed. Allotment results usually come within a few days, and listing on NEPSE follows some weeks later.

How to check your IPO result

Opens the official site in a new tab. Your BOID stays between you and CDSC; NepsezAI never asks for it.

TrancheStatusUnitsPriceOpensClosesLast dateListedIssue manager
general publicClosed17,00,000100————Muktinath Capital Limited
general publicPipeline17,00,000—————Muktinath Capital Limited

KPLL IPO FAQs

How many units does the Kantipur Pharmaceuticals Lab Limited IPO offer, and at what price?
17,00,000 units at Rs 100 per share for the general public.
Who is the issue manager for the KPLL IPO?
Muktinath Capital Limited.
How do I check the Kantipur Pharmaceuticals Lab Limited IPO result?
On iporesult.cdsc.com.np choose Kantipur Pharmaceuticals Lab Limited and enter your BOID, or in MeroShare open My ASBA → Application Report.
What is the minimum application for the KPLL IPO?
Normally 10 units. When an issue is oversubscribed, allotment is a lottery over applications, so applying for more units does not raise your chance.

Full IPO calendar · How to apply through MeroShare